Jean-Simon Diallo

14PUBLICATIONS
89CO-AUTHORS
Agricultural molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 30, 2025
Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields.

Sven Göbel, Tilia Zinnecker, Ingo Jordan

|Mar 10, 2025
Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer.

Alison O Cudmore, Galaxia M Rodriguez, Vincent Maranda

|Dec 20, 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.

Naziia Kurmasheva, Aida Said, Boaz Wong

|Aug 23, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.

Zaid Taha, Mathieu Joseph François Crupi, Nouf Alluqmani

|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.

Naziia Kurmasheva, Aida Said, Boaz Wong

|Apr 08, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.

Marie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi

Pageof 3

Frequent Collaborators

4 joint publications

Dominic Guy Roy

4 joint publications

Zaid Taha

4 joint publications

John Cameron Bell

3 joint publications

Rozanne Arulanandam